Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Healthequity (HQY) Revenue (2016 - 2025)

Historic Revenue for Healthequity (HQY) over the last 13 years, with Q4 2025 value amounting to $322.2 million.

  • Healthequity's Revenue rose 723.36% to $322.2 million in Q4 2025 from the same period last year, while for Oct 2025 it was $1.3 billion, marking a year-over-year increase of 1219.77%. This contributed to the annual value of $1.2 billion for FY2025, which is 2002.7% up from last year.
  • Healthequity's Revenue amounted to $322.2 million in Q4 2025, which was up 723.36% from $325.8 million recorded in Q3 2025.
  • In the past 5 years, Healthequity's Revenue registered a high of $330.8 million during Q2 2025, and its lowest value of $180.0 million during Q4 2021.
  • Over the past 5 years, Healthequity's median Revenue value was $244.0 million (recorded in 2023), while the average stood at $249.2 million.
  • In the last 5 years, Healthequity's Revenue tumbled by 647.66% in 2021 and then skyrocketed by 2314.89% in 2024.
  • Over the past 5 years, Healthequity's Revenue (Quarter) stood at $180.0 million in 2021, then increased by 20.08% to $216.1 million in 2022, then grew by 15.33% to $249.2 million in 2023, then rose by 20.55% to $300.4 million in 2024, then rose by 7.23% to $322.2 million in 2025.
  • Its Revenue stands at $322.2 million for Q4 2025, versus $325.8 million for Q3 2025 and $330.8 million for Q2 2025.